Clinical Trial Results:
A randomized, multi-center cross-over study to evaluate patient preference and Health Care Professional (HCP) satisfaction with subcutaneous (SC) administration of trastuzumab in HER2-positive early breast cancer (EBC)
Summary
|
|
EudraCT number |
2010-024099-25 |
Trial protocol |
ES SE GB DK DE IT |
Global completion date |
23 May 2013
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1 |
This version publication date |
19 Aug 2016
|
First version publication date |
19 Aug 2016
|
Other versions |
v2 |
Summary report(s) |
MO22982 CTg Receipt |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.